Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Kolb · SciRah

Researcher profile · Semantic Scholar

H. Kolb

Share profile

H. Kolb — researcher profile on SciRah

h-index: 13
Works: 43
Citations: 893

Most-cited papers

Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo.
M. Absinta, P. Sati, Federica Masuzzo, G. Nair +6 more
2019JAMA Neurology504 citations Open access
Semantic Scholar
7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis Lesions
H. Kolb, M. Absinta, E. Beck, S. Ha +6 more
2021Annals of Neurology66 citations Open access
Semantic Scholar
Role of Immunosuppressive Therapy for the Treatment of Multiple Sclerosis
J. Stankiewicz, H. Kolb, A. Karni, H. Weiner
2012Neurotherapeutics42 citations Open access
Semantic Scholar
From pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesions
H. Kolb, O. Al-Louzi, E. Beck, P. Sati +2 more
2022NeuroImage: Clinical40 citations Open access
Semantic Scholar
Real-World experience with efgartigimod in patients with myasthenia gravis
Lior Fuchs, S. Shelly, I. Vigiser, H. Kolb +5 more
2024Journal of Neurology39 citations
Semantic Scholar
Tuberculosis diagnostic delay and therapy outcomes of non-national migrants in Tel Aviv, 1998-2008.
Z. Mor, H. Kolb, M. Lidji, G. Migliori +1 more
2013Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin36 citations Open access
Semantic Scholar
BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves
Alon Doron, Y. Piura, I. Vigiser, H. Kolb +3 more
2022Journal of Neurology16 citations Open access
Semantic Scholar
Reinforcing the evidence of oligoclonal bands as a prognostic factor in patients with Multiple sclerosis.
G. Ben Noon, I. Vigiser, T. Shiner, H. Kolb +2 more
2021Multiple Sclerosis and Related Disorders16 citations
Semantic Scholar
Navigator-Guided Motion and B0 Correction of T2*-weighted MRI Improves Multiple Sclerosis Cortical Lesion Detection
Jiaen Liu, E. Beck, S. Filippini, P. van Gelderen +9 more
2021Investigative Radiology15 citations Open access
Semantic Scholar
Smartphone-based gait assessment for multiple sclerosis.
K. Regev, Noa Eren, Ziv Yekutieli, Keren Karlinski +5 more
2023Multiple Sclerosis and Related Disorders14 citations
Semantic Scholar
New Insights on DR and DQ Human Leukocyte Antigens in Anti-LGI1 Encephalitis
Yahel Segal, Michal Nisnboym, K. Regev, Karni Arnon +11 more
2023Neurology: Neuroimmunology & Neuroinflammation13 citations Open access
Semantic Scholar
Fingolimod Increases Brain-Derived Neurotrophic Factor Level Secretion from Circulating T Cells of Patients with Multiple Sclerosis
M. Golan, Karin Mausner-Fainberg, Bassima Ibrahim, Moshe Benhamou +4 more
2019CNS Drugs13 citations
Semantic Scholar
Characterization of patients with ocular myasthenia gravis — A case series
A. Karni, Ali Asmail, V. Drory, H. Kolb +1 more
2016eNeurologicalSci13 citations Open access
Semantic Scholar
A tri-modal distribution of age-of-onset in female patients with myasthenia gravis is associated with the gender-related clinical differences
Ali Asmail, A. Kesler, H. Kolb, V. Drory +1 more
2018International Journal of Neuroscience10 citations
Semantic Scholar
Ultrahigh-resolution MRI Reveals Extensive Cortical Demyelination in a Nonhuman Primate Model of Multiple Sclerosis.
M. Donadieu, Hannah M. Kelly, D. Szczupak, Jing-Ping Lin +10 more
2020Cerebral Cortex9 citations Open access
Semantic Scholar
Heterogeneous response to efgartigimod in real-world experience with myasthenia gravis: Predictors and treatment strategies
Lior Fuchs, I. Vigiser, H. Kolb, K. Regev +13 more
2026Neurotherapeutics7 citations Open access
Semantic Scholar
The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis
Ido Har-Shalom, A. Karni, H. Kolb
2021International Journal of Molecular Sciences7 citations Open access
Semantic Scholar
Increased Expression of Ephrins on Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis Affects Oligodendrocyte Differentiation
M. Golan, A. Krivitsky, Karin Mausner-Fainberg, Moshe Benhamou +4 more
2021International Journal of Molecular Sciences6 citations Open access
Semantic Scholar
CTGF/CCN2 has a possible detrimental role in the inflammation and the remyelination failure in the early stages of multiple sclerosis.
L. Fuchs, Karin Mausner-Fainberg, Anna Luban, S. Asseyer +9 more
2022Journal of Neuroimmunology5 citations
Semantic Scholar
Increased neutralization capacity of TNF-α in sera of relapsing remitting multiple sclerosis patients is not related to soluble TNF-α receptors or anti-TNF-α autoantibody levels.
Karin Mausner-Fainberg, K. Regev, H. Kolb, A. Vaknin-Dembinsky +1 more
2015Journal of Neuroimmunology5 citations
Semantic Scholar
Effect of ethnic origin and gender on the clinical manifestations of myasthenia gravis among the Jewish population in Israel.
Ali Asmail, A. Kesler, V. Drory, H. Kolb +1 more
2017Journal of Neuroimmunology4 citations
Semantic Scholar
Thymus involvement in myasthenia gravis: Epidemiological and clinical impacts of different self-tolerance breakdown mechanisms.
A. Karni, Ali Asmail, V. Drory, H. Kolb +1 more
2016Journal of Neuroimmunology4 citations
Semantic Scholar
Clinical Characterization and Prognostic Risk Factors of Susac Syndrome
Lior Fuchs, A. Wilf-Yarkoni, H. Kolb, I. Vigiser +12 more
2024Neurology(R) neuroimmunology & neuroinflammation2 citations
Semantic Scholar
Long-term cognitive outcomes in Susac syndrome: A case series.
Y. Piura, Noa Bregman, G. Kavé, A. Karni +6 more
2024Journal of Neuroimmunology2 citations
Semantic Scholar
Differences in MS clinical and epidemiological characteristics between Ashkenazi and non-Ashkenazi Jewish patients in Israel: a retrospective single center study
A. Karni, Gil Ben Noon, T. Shiner, I. Vigiser +2 more
2022Scientific Reports2 citations Open access
Semantic Scholar
Differential screening-selected gene aberrative in neuroblastoma (DAN) is increased in the CSF of patients with MS and may be induced by therapy with interferon-β.
Karin Mausner-Fainberg, H. Kolb, Moran Penn, K. Regev +4 more
2016Journal of Neuroimmunology2 citations
Semantic Scholar
GA Depot (Long-acting IM Injection of Glatiramer Acetate) Presents Improved Safety and Tolerability Features: Results from a Multinational, Double-blind, Placebo-controlled Phase III Study in Subjects with Relapsing Forms of Multiple Sclerosis (P8-6.018)
Aaron Miller, L. Popper, H. Kolb, N. Kimelman +3 more
2024Neurology1 citations
Semantic Scholar
Olfactory function in Susac syndrome.
Y. Piura, A. Karni, H. Kolb, I. Vigiser +1 more
2023Clinical neurology and neurosurgery (Dutch-Flemish ed. Print)1 citations
Semantic Scholar
The Risk of ICH in Cancer Patients Treated with Intravenous Thrombolysis for Acute Ischemic Stroke (P06.263)
H. Kolb, S. Bloch, N. Borenstein, H. Hallevi
2013Neurology1 citations
Semantic Scholar
Bronchiectasis in Myasthenia Gravis: A Clinically Relevant Comorbidity Defining a High-risk Triad With Thymoma (P4-9.014)
I. Vigiser, Alon Doron, K. Regev, H. Kolb +3 more
2026Neurology0 citations
Semantic Scholar
Bronchiectasis in Myasthenia Gravis: A Clinically Relevant Comorbidity Defining a High-Risk Triad with Thymoma 2307376
A. Karni, Alon Doron, A. Bar-Shai, H. Kolb +2 more
2026Journal of Immunology0 citations
Semantic Scholar
Circulating microRNA expression profiles as biomarkers of disease activity in multiple sclerosis
I. Vigiser, Yoav Zeevi, Y. Piura, H. Kolb +3 more
2026Multiple Sclerosis Journal - Experimental, Translational and Clinical0 citations Open access
Semantic Scholar
GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trial
A. Miller, J. A. Cohen, A. Karni, L. Popper +9 more
2026Multiple Sclerosis0 citations
Semantic Scholar
Circulating microRNA as biomarkers for predicting cladribine response in multiple sclerosis
I. Vigiser, Yoav Zeevi, Y. Piura, H. Kolb +3 more
2026Scientific Reports0 citations Open access
Semantic Scholar
Real-world Outcomes of Efgartigimod in AChR-Positive Generalized Myasthenia Gravis: Response Patterns, Predictors, and Treatment Strategies (S14.002)
Lior Fuchs, I. Vigiser, H. Kolb, K. Regev +13 more
2026Neurology0 citations
Semantic Scholar
GA Depot (Long-acting IM Glatiramer Acetate) and its Impact on EDSS in Relapsing Forms of Multiple Sclerosis (RMS) and Primary Progressive Multiple Sclerosis (PPMS) (P7-19.002)
Aaron Miller, L. Popper, Joseph Berger, Amit Bar-Or +8 more
2026Neurology0 citations
Semantic Scholar
Intrathecal methotrexate in progressive multiple sclerosis: a phase 1 open-label study with long-term follow-up
H. Kolb, Y. Shachaf, Karin Fainberg, Maya Golan +12 more
2025Journal of Neurology0 citations
Semantic Scholar
GA Depot (Long-acting IM Injection of Glatiramer Acetate) Impact on EDSS Stability in Relapsing Forms of Multiple Sclerosis (RMS) and Primary Progressive Multiple Sclerosis (PPMS) (P11-1.014)
Aaron Miller, L. Popper, Joseph Berger, Amit Bar-Or +9 more
2025Neurology0 citations
Semantic Scholar
Long-term Cognitive Outcomes in Susac Syndrome (P8-14.003)
Y. Piura, Noa Bregman, G. Kavé, A. Karni +4 more
2024Neurology0 citations
Semantic Scholar
BNT162b2 mRNA COVID-19 Vaccine Three-Dose Safety and Risk of COVID-19 in Patients With Myasthenia Gravis
Alon Doron, Y. Piura, I. Vigiser, H. Kolb +3 more
2022Neurology0 citations Open access
Semantic Scholar
Expanding Our Knowledge of the Immunogenetic Characteristics of Anti-LGI1 Encephalitis—A Study of an Israeli Cohort Suggests Additional Significant HLA Associations With DQ Alleles
Yahel Segal, Michal Nisnboym, K. Regev, A. Karni +10 more
2022Neurology0 citations
Semantic Scholar
Evaluating the Performance of an Atlas-Free Automated Method of Brain Classification for Lesion Segmentation in Progressive Multifocal Leukoencephalopathy (4958)
H. Kolb, Daniel S. Reich, I. Cortese, G. Nair
2020Neurology0 citations
Semantic Scholar
Role of Immunosuppressive Therapy for the Treatment of Multiple Sclerosis
J. Stankiewicz, H. Kolb, A. Karni, H. Weiner
2012Neurotherapeutics0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Karni×33
Invite
A. Karni — researcher profile on SciRah
K. Regev×24
Invite
K. Regev — researcher profile on SciRah
I. Vigiser×19
Invite
I. Vigiser — researcher profile on SciRah
Y. Piura×8
Invite
Y. Piura — researcher profile on SciRah

×6

Invite

V. Drory — researcher profile on SciRah

Invite

P. Sati — researcher profile on SciRah

Invite

D. Reich — researcher profile on SciRah

Invite

Lior Fuchs — researcher profile on SciRah

Karin Mausner-Fainberg×5

Invite

Karin Mausner-Fainberg — researcher profile on SciRah

Invite

E. Beck — researcher profile on SciRah

Invite

Alon Doron — researcher profile on SciRah

Invite

T. Shiner — researcher profile on SciRah